Literature DB >> 19867526

GLOMERULAR LESIONS OF SUBACUTE BACTERIAL ENDOCARDITIS.

G Baehr1.   

Abstract

1. In most cases of chronic or subacute bacterial endocarditis due to the endocarditis coccus (Streptococcus viridans), there exists a distinctive pathological lesion in some of the glomeruli due to bacterial emboli. 2. The salient features of the pathological picture are first, the involvement of one or more loops of a variable number of glomeruli; secondly, the absence of any visible disease in the uninvolved glomeruli and in the uninvolved portions of affected glomeruli; and thirdly, the association in most of the bacterial cases of all the various stages of the glomerular process often seen in a single microscopical section. 3. The lesion does not occur in cases of acute endocarditis, and up to the present time it has been absent in cases of subacute bacterial endocarditis due to organisms other than the endocarditis coccus. 4. In a group of cases having vegetations that are typical of those in the active stage of subacute endocarditis (except that they are free from bacteria and healing or healed), the healed stage of this distinctive glomerular lesion is present, although it is less extensive than in the active bacterial cases. 5. These cases, therefore, are most probably examples of subacute bacterial endocarditis due originally to the endocarditis coccus, but in which the endocardial vegetations have become free from bacteria rather early in their course and are now healing or healed, as claimed by Harbitz and Libman. 6. During the active bacterial stage of the disease, if the glomerular lesions are not too numerous, the only symptoms produced will be an almost constant hematuria, usually demonstrable only microscopically. If the glomerular lesions are very numerous, symptoms resembling those of subacute hemorrhagic nephritis may occur and may even cause a fatal issue. If the glomerular lesions are very numerous but not sufficient to cause death, and the cardiac lesion should go on to healing, a contracted kidney, secondary to the glomerular lesion, may subsequently ensue and produce the typical symptoms and death. In such a case, the finding of the healed or healing lesion of subacute bacterial endocarditis will be accidental.

Entities:  

Year:  1912        PMID: 19867526      PMCID: PMC2124924          DOI: 10.1084/jem.15.4.330

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  [ESC and AHA guidelines 2015 on endocarditis : In competition or synchrony?]

Authors:  Bernhard Maisch
Journal:  Herz       Date:  2016-12       Impact factor: 1.443

Review 2.  Regulation of food intake by oleoylethanolamide.

Authors:  J Lo Verme; S Gaetani; J Fu; F Oveisi; K Burton; D Piomelli
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

3.  Crescentic involved glomerulonephritis in infective endocarditis.

Authors:  T Tóth
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 4.  Infective Endocarditis-Associated Glomerulonephritis: A Comprehensive Review of the Clinical Presentation, Histopathology, and Management.

Authors:  Tomoaki Takata; Yukari Mae; Takaaki Sugihara; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2022-01-28       Impact factor: 1.641

5.  A STUDY OF EXPERIMENTAL NON-HEMOLYTIC STREPTOCOCCUS LESIONS IN VITALLY STAINED RABBITS.

Authors:  R L Cecil
Journal:  J Exp Med       Date:  1916-12-01       Impact factor: 14.307

6.  Update on endocarditis-associated glomerulonephritis.

Authors:  Christie L Boils; Samih H Nasr; Patrick D Walker; William G Couser; Christopher P Larsen
Journal:  Kidney Int       Date:  2015-01-21       Impact factor: 10.612

7.  Infective endocarditis: a history of the development of its understanding.

Authors:  Stephen A Geller
Journal:  Autops Case Rep       Date:  2013-12-31

8.  Two Cases of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody (PR3-ANCA)-related Nephritis in Infectious Endocarditis.

Authors:  Kazuya Hirai; Naoto Miura; Masabumi Yoshino; Kanyu Miyamoto; Hironobu Nobata; Takuhito Nagai; Keisuke Suzuki; Shogo Banno; Hirokazu Imai
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.